Shibing Yang is a Director at Genmab since June 2022, specializing in CORE. Prior experience includes serving as Director of Value Evidence & Outcomes and Value Evidence Manager at GSK from July 2014 to June 2022, where responsibilities involved planning and delivering clinical and economic evidence for assets throughout development phases. Shibing Yang also held roles as Manager of Real-World Data & Analytics and Senior Epidemiologist. Earlier experience includes a Graduate Research Assistant position at Virginia Commonwealth University from August 2010 to June 2014 and an internship at the World Health Organization China Office in 2010. Academic qualifications comprise a PhD in Epidemiology from Virginia Commonwealth University, a Master's degree in Healthcare Administration from Capital University of Medical Sciences, and a Bachelor's degree in Preventive Medicine from Capital Medical University.